<?xml version="1.0" encoding="UTF-8"?>
<p id="Par44">We hypothesise that HA-SIB-WBRT will be able to increase both target tumour and intracranial disease control compared with HA-WBRT alone. This, therefore, has the potential to impact on survival outcomes whilst maintaining cognitive function and quality of life.</p>
